Evidence map›Paper›PMID 41299524›Full record

Trial reportJournal of neuroengineering and rehabilitation2025

Cost-effectiveness analysis of the MYO Armband

Selena Marcos-Antón, Roberto Cano-de-la-Cuerda, Isaac Aranda-Reneo, Alberto Jardón-Huete, Edwin Daniel Oña-Simbaña, Juan Oliva-Moreno

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of neuroengineering and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Selena Marcos-AntónFaculty of Health Sciences, Universidad Villanueva, C. de la Costa Brava, 2, Fuencarral-El Pardo, Madrid, 28034, Spain.
Roberto Cano-de-la-CuerdaDepartment of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Faculty of Health Sciences, Rey Juan Carlos University, Alcorcón, Madrid, 28922, Spain. roberto.cano@urjc.es.
Isaac Aranda-ReneoDepartment of Economic Analysis and Finance, University of Castilla-La Mancha, Talavera de la Reina, Spain. isaac.aranda@uclm.es.
Alberto Jardón-HueteRobotics Lab, Department of Systems Engineering and Automation, University Carlos III of Madrid, Madrid, 28911, Leganés, Spain.
Edwin Daniel Oña-SimbañaRobotics Lab, Department of Systems Engineering and Automation, University Carlos III of Madrid, Madrid, 28911, Leganés, Spain.
Juan Oliva-MorenoCIBERFES, ISCIII, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe rapid and extensive expansion of virtual reality (VR) across all medical specialties, including neurorehabilitation, has significantly enhanced and broadened the treatment options for individuals with neurological disorders. The objective of the present study was to carry out an economic analysis of the MYO Armband

methodsA randomized controlled trial was conducted. The sample was randomly assigned to two groups: an experimental group (EG) that received UL rehabilitation through serious games developed by the research team and controlled with the MYO Armband

resultsThe total costs in the CG amounted to 5,721.1 euros compared to 6,240.4 euros for the EG, with a cost difference between intervention and control of 35 euros per patient. The MYO Armband

conclusionThe use of MYO Armband

Indexed as

Cost-Benefit AnalysisMultiple SclerosisNeurological RehabilitationUpper ExtremityVideo GamesAdultCost-Effectiveness AnalysisFemaleHand StrengthHumansMaleMiddle AgedRange of Motion, ArticularCost-effectiveEconomic evaluationMultiple sclerosisMYO armbandRehabilitationUpper limbVideo gamesVirtual reality

Identifiers

PMID41299524
PMCPMC12866502

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.